Tianjin Chase Sun Pharmaceutical Co.,Ltd (SHE:300026)
4.040
-0.020 (-0.49%)
Jul 18, 2025, 2:45 PM CST
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
Traditional Chinese Medicine Formula Granules and Decoction Pieces | 2.92B | Log In | Log In | Log In | Log In | Upgrade |
Traditional Chinese Medicine Formula Granules and Decoction Pieces Growth | -12.99% | Log In | Log In | Log In | Log In | Upgrade |
Blood-essential Injection | 851.29M | Log In | Log In | Log In | Log In | Upgrade |
Blood-essential Injection Growth | 4.23% | Log In | Log In | Log In | Log In | Upgrade |
Smart Pharmaceutical Supply Chain | 714.90M | Log In | Log In | Log In | Log In | Upgrade |
Smart Pharmaceutical Supply Chain Growth | 21.66% | Log In | Log In | Log In | Log In | Upgrade |
Medical Device | 383.12M | Log In | Log In | Log In | Log In | Upgrade |
Medical Device Growth | -43.12% | Log In | Log In | Log In | Log In | Upgrade |
Excipients | 343.71M | Log In | Log In | Log In | Log In | Upgrade |
Excipients Growth | -4.80% | Log In | Log In | Log In | Log In | Upgrade |
Low Molecular Weight Heparin Calcium Injection | 287.21M | Log In | Log In | Log In | Log In | Upgrade |
Low Molecular Weight Heparin Calcium Injection Growth | -5.82% | Log In | Log In | Log In | Log In | Upgrade |
Moxifloxacin Hydrochloride Sodium Chloride Injection | 189.43M | Log In | Log In | Log In | Log In | Upgrade |
Moxifloxacin Hydrochloride Sodium Chloride Injection Growth | 14.49% | Log In | Log In | Log In | Log In | Upgrade |
Other Products | 188.86M | Log In | Log In | Log In | Log In | Upgrade |
Other Products Growth | -18.85% | Log In | Log In | Log In | Log In | Upgrade |
API | 156.24M | Log In | Log In | Log In | Log In | Upgrade |
API Growth | 6.07% | Log In | Log In | Log In | Log In | Upgrade |
Other | 70.76M | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | 7654.97% | Log In | Log In | Log In | Log In | Upgrade |
Fasudil Hydrochloride Injection | - | Log In | Log In | Log In | Log In | Upgrade |
Fasudil Hydrochloride Injection Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
China | 5.17B | Log In | Log In | Log In | Log In | Upgrade |
China Growth | -12.77% | Log In | Log In | Log In | Log In | Upgrade |
Overseas | 361.28M | Log In | Log In | Log In | Log In | Upgrade |
Overseas Growth | -50.29% | Log In | Log In | Log In | Log In | Upgrade |